212116-78-4

C16 PEG Ceramide, MW 750 is used for liposome preparation with NMR studies and PEGylated lipoplexes preparation.

C16 PEG5000 Ceramide might be used to stabilize nanosized bilayer disks and in the preparation of lipid aggregates.

C16 PEG750 Ceramide might be used as a control to test for nonspecific interactions during titrations of DNA-nanotube complexes with polyethylene glycol (PEG)-conjugated lipids.

Ceramide is a sphingolipid metabolite. The ceramides differ in their acyl chain length.

Therapeutic drugs enclosed in poly-ethylene glycol (PEG) conjugated ceramide serves as liposomal carriers, ensuring a longer circulation period. It exhibits a neutral surface electrostatic charge which prevents the leakage of positively charged encapsulated drug molecule.

[1] KENJI KUSUMOTO. Effect of the anchor in polyethylene glycol-lipids on the transfection activity of PEGylated cationic liposomes encapsulating DNA.[J]. Biological & pharmaceutical bulletin, 2012, 35 4: 445-448. DOI: 10.1248/bpb.35.445
[2] ALEKSANDRA M. URBANSKA . Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer[J]. Biomaterials, 2012, 33 18: Pages 4752-4761. DOI: 10.1016/j.biomaterials.2012.03.023
[3] LEE Y, JEONG M, LEE G, et al. Development of Lipid Nanoparticle Formulation for the Repeated Administration of mRNA Therapeutics[J]. ACS Biomaterials Science & Engineering, 2024, 221 3. DOI: 10.34133/bmr.0017